Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function

Cardiovascular Research

Volumn 83, Issue 2, 2009, Pages 362-370

  Chaudhary, Ketul R ^a   Batchu, Sri Nagarjun ^a   Das, Dipankar ^a   Suresh, Mavanur R ^a   Falck, John R ^b   Graves, Joan P ^c   Zeldin, Darryl C ^c   Seubert, John M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

B type natriuretic peptide; Epoxyeicosatrienoic acid; GSK 3 ; Ischaemia reperfusion

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; EPOXYICOSATRIENOIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 8,11,14-EICOSATRIENOIC ACID; ANIMALS; ATRIAL NATRIURETIC FACTOR; CHROMONES; EPOXIDE HYDROLASES; FEMALE; GLYCOGEN SYNTHASE KINASE 3; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA, HEART; MORPHOLINES; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PERFUSION; PHOSPHORYLATION; PROTEIN KINASE C-EPSILON; PROTEIN KINASE INHIBITORS; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RECOMBINANT PROTEINS; RECOVERY OF FUNCTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRAHYDROISOQUINOLINES; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 67650221165     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp134     Document Type: Article

References (43)

1. Schmelzer KR, Kubala L, Newman JW, Kim IH, Eiserich JP, Hammock BD. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci USA 2005;102:9772-9777.
2. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002;82:131-185.
3. 2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex. Neurosci Lett 1997;233:97-100.
4. Larsen BT, Miura H, Hatoum OA, Campbell WB, Hammock BD, Zeldin DC et al. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition. Am J Physiol Heart Circ Physiol 2006;290:H491-H499.
5. Fang X, Weintraub NL, McCaw RB, Hu S, Harmon SD, Rice JB et al. Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. Am J Physiol Heart Circ Physiol 2004;287:H2412-H2420.
6. Pain T, Yang XM, Critz SD, Yue Y, Nakano A, Liu GS et al. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 2000;87:460-466.
7. Dhanasekaran A, Gruenloh SK, Buonaccorsi JN, Zhang R, Gross GJ, Falck JR et al. Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am J Physiol Heart Circ Physiol 2008; 294:H724-H735.
8. Lu T, Ye D, Wang X, Seubert JM, Graves JP, Bradbury JA et al. Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms. J Physiol 2006;575:627-644.
9. Seubert JM, Goralski K, Sinal CJ, Murphy E, Zeldin DC. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circulation (Suppl.) 2004;110:808.
10. Seubert JM, Zeldin DC, Nithipatikom K, Gross GJ. Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury. Prostaglandins Other Lipid Mediat 2007;82:50-59.
11. Wu S, Moomaw CR, Tomer KB, Falck JR, Zeldin DC. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 1996;271:3460-3468.
12. Alkayed NJ, Birks EK, Narayanan J, Petrie KA, Kohler-Cabot AE, Harder DR. Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood flow to glutamate in rats. Stroke 1997;28:1066-1072.
13. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004;113:1535-1549.
14. Seubert JM, Sinal CJ, Graves J, DeGraff LM, Bradbury JA, Lee CR et al. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res 2006;99:442-450.
15. Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3- kinase-dependent pathway is cardioprotective. Circ Res 2002;90:377-379.
16. Hanlon PR, Fu P, Wright GL, Steenbergen C, Arcasoy MO, Murphy E. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling. FASEB J 2005;19:1323-1325.
17. Silver MA. The natriuretic peptide system: kidney and cardiovascular effects. Curr Opin Nephrol Hypertens 2006;15:14-21.
18. Krupicka J, Janota T, Kasalova Z, Hradec J. Natriuretic peptides-physiology, pathophysiology and clinical use in heart failure. Physiol Res 2008
19. Burley DS, Hamid SA, Baxter GF. Cardioprotective actions of peptide hormones in myocardial ischemia. Heart Fail Rev 2007;12:279-291.
20. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007;11:37-51.
21. D'souza SP, Baxter GF. B Type natriuretic peptide: a good omen in myocardial ischaemia? Heart 2003;89:707-709.
22. Tenhunen O, Szokodi I, Ruskoaho H. Posttranscriptional activation of BNP gene expression in response to increased left ventricular wall stress: role of calcineurin and PKC. Regul Pept 2005;128:187-196.
23. Nakao K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides. J Hypertens 1992; 10:907-912.
24. Shahhosseini S, Guttikonda S, Bhatnagar P, Suresh MR. Production and characterization of monoclonal antibodies against shope fibroma virus superoxide dismutase and glutathione-S-transferase. J Pharm Pharm Sci 2006;9:165-168.
25. Das D, Suresh MR. Copious production of SARS-CoV nucleocapsid protein employing codon optimized synthetic gene. J Virol Methods 2006; 137:343-346.
26. Das D, Jacobs F, Feldmann H, Jones SM, Suresh MR. Differential expression of the Ebola virus GP(1,2) protein and its fragments in E. coli. Protein Expr Purif 2007;54:117-125.
27. Seubert J, Yang B, Bradbury JA, Graves J, Degraff LM, Gabel S et al. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. Circ Res 2004;95:506-514.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
29. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM et al. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res 2002;90:390-397.
30. D'souza SP, Davis M, Baxter GF. Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 2004;101:113- 129.
31. D'souza SP, Yellon DM, Martin C, Schulz R, Heusch G, Onody A et al. B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol 2003; 284:H1592-H1600.
32. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995;92:1558-1564.
33. Kudoh S, Akazawa H, Takano H, Zou Y, Toko H, Nagai T et al. Stretch-modulation of second messengers: effects on cardiomyocyte ion transport. Prog Biophys Mol Biol 2003;82:57-66.
34. Tokola H, Hautala N, Marttila M, Magga J, Pikkarainen S, Kerkela R et al. Mechanical load-induced alterations in B-type natriuretic peptide gene expression. Can J Physiol Pharmacol 2001;79:646-653.
35. He Q, Wang D, Yang XP, Carretero OA, LaPointe MC. Inducible regulation of human brain natriuretic peptide promoter in transgenic mice. Am J Physiol Heart Circ Physiol 2001;280:H368-H376.
36. He Q, LaPointe MC. Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension 1999;33:283-289.
37. Hanford DS, Glembotski CC. Stabilization of the B-type natriuretic peptide mRNA in cardiac myocytes by alpha-adrenergic receptor activation: potential roles for protein kinase C and mitogen-activated protein kinase. Mol Endocrinol 1996;10:1719-1727.
38. Weber M, Mitrovic V, Hamm C. B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide: diagnostic role in stable coronary artery disease. Exp Clin Cardol 2006;11:99-101.
39. Potthast R, Potter LR. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptors. Peptides 2005;26:1001-1008.
40. Kim MY, Kim MJ, Yoon IS, Ahn JH, Lee SH, Baik EJ et al. Diazoxide acts more as a PKC-epsilon activator, and indirectly activates the mitochondrial K(ATP) channel conferring cardioprotection against hypoxic injury. Br J Pharmacol 2006;149:1059-1070.
41. Nishihara M, Miura T, Miki T, Tanno M, Yano T, Naitoh K et al. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cardiol 2007; 43:564-570.
42. Das S, Wong R, Rajapakse N, Murphy E, Steenbergen C. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res 2008;103:910-913.
43. Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res 2004;94:960-966.